Objective To explore the effect of pulmonary surfactant (PS) combined with mechanical ventilation on pulmonary hyaline membrane disease of newborn (HMD) in newborn.
目的探讨肺表面活性物质（PS）与机械通气联用治疗新生儿肺透明膜病（HMD）的疗效及临床价值。
Objective To evaluate the effect of exogenous pulmonary surfactant (PS) replacement therapy for infants who suffered pulmonary injury after cardiopulmonary bypass.
目的评价外源性肺泡表面活性物质(PS)治疗婴儿体外循环后肺损伤的疗效。
URPOSE to assess the efficacy of a combined inhaled nitric oxide (INO) and intratracheal exogenous pulmonary surfactant (PS) therapy in experimental acute respiratory distress syndrome (ARDS).
探讨联合应用吸入一氧化氮(INO)和肺表面活性物质(PS)对实验性急性呼吸窘迫综合征(ARDS)的治疗作用。
Objective To evaluate the efficacy and safety of pulmonary surfactant(PS)in the replacement therapy for neonatal respiratory distress syndrome(NRDS).
目的评价肺表面活性物质 （PS）替代治疗新生儿呼吸窘迫综合症 （NRDS ）的疗效及安全性。
Objective The aim of this study was to determine the therapeutic effect of pulmonary surfactant (PS) on the development of bronchopulmonary dysplasia (BPD) in premature infants.
目的探讨肺表面活性物质（PS）对支气管肺发育不良（BPD）的预防和治疗意义。
Observated under the microscope, the pulmonary surfactant (PS) preparation consists of the bulb and the stick vacuole aggregation.
显微镜下观察ps制剂是由液泡球状和液泡棒状聚集物组成。
Pulmonary surfactants (PS) is important to maintain the normal lung function, and surfactant alterations have been implicated in the pathophysiology of acute respiratory distress syndrome (ARDS).
肺表面活性物质(PS)在维持正常的肺功能起着重要作用，业已证明，PS异常与急性呼吸窘迫综合征(ARDS)的发病有关。
Pulmonary surfactants (PS) is important to maintain the normal lung function, and surfactant alterations have been implicated in the pathophysiology of acute respiratory distress syndrome (ARDS).
肺表面活性物质(PS)在维持正常的肺功能起着重要作用，业已证明，PS异常与急性呼吸窘迫综合征(ARDS)的发病有关。
应用推荐